Spain· ES:1231736014
OMVOH 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
A medicinal product containing mirikizumab, registered in Spain by Eli Lilly Nederland B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- mirikizumab
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirikizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOMVOHEli Lilly Nederland B.V., Utrecht
- IcelandOmvohEli Lilly Nederland B.V.*
- SwedenOmvoh 200 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- BelgiumOmvoh 200 mgEli Lilly Nederland
- NorwayOmvohEli Lilly Nederland B.V.
- PolandOmvohEli Lilly Nederland B.V.
- SwitzerlandOmvoh 200 mg, solution injectable en seringue préremplieEli Lilly (Suisse) SA
- United StatesOmvohEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Omvoh
- Liechtenstein · Omvoh
- Norway · Omvoh
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6c7c1789-1d5e-446b-bcc7-23c8d2fbfccb GET /v1/drugs/6c7c1789-1d5e-446b-bcc7-23c8d2fbfccb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1757068702000}",
"nregistro": "1231736014",
"substance": "mirikizumab"
}See everything about mirikizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.